Clinical Trial Update: Camrelizumab With Chemotherapy in Adults With Medically Inoperable Early Stage NSCLC [Phase 2]

View source ↗

Summary

Phase 2 trial update exploring camrelizumab with chemotherapy in adults with medically inoperable early stage non-small cell lung cancer.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Non-small Cell Lung Cancer

Drugs mentioned

• Camrelizumab (camrelizumab)

Snippet

Sponsor: Tianjin Medical University Cancer Institute and Hospital | Conditions: Early Stage Non-small Cell Lung Cancer | Phase 2 | Status: UNKNOWN